Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.640
+0.050 (3.14%)
At close: Oct 24, 2025, 4:00 PM EDT
1.610
-0.030 (-1.83%)
After-hours: Oct 24, 2025, 4:18 PM EDT
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $66.82 million as of October 24, 2025. Its market cap has decreased by -74.97% in one year.
Market Cap
66.82M
Enterprise Value
39.43M
1-Year Change
-74.97%
Ranking
Category
Stock Price
$1.64
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $66.82M, a decrease of -94.99%. That is a compound annual growth rate of -44.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 66.82M | -75.08% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | 2.46B | 84.60% |
| Oct 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |